NCT01218204
- Conditions
- Dyslipidaemias, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Chula Vista, California, United States
- GSK Investigational Site Stockton, California, United States
- GSK Investigational Site Jacksonville, Florida, United States